Free digital presence assessment for new clients
B2B LEAD GENERATION - HEALTHCARE

From media reach to
122 new B2B opportunities

<p>An acquisition system for approaching pharmacies, featuring clear targeting, a conversion path, and measurement spanning from interaction to lead.</p>

CLIENT

Acme

Farmabijoux partner acquisition

SERVICE STACK

  • Digital Strategy
  • Performance Marketing
  • Landing & Measurement

122

pharmacy leads

01 · ΤΗΕ CHALLENGE

The market was specific. The approach had to be precise.

The goal was not the mass collection of contacts, but the creation of meaningful business opportunities with pharmacy professionals.

Audience

A limited, professional audience with a different intent than the end consumer.

Conversion

The information had to lead to a clear next step without unnecessary friction.

Measurement

Each lead had to be linked to its source and acquisition cost.


02 · THE STRATEGY

A unified funnel, from targeting to sales follow-up.

01

Segmentation & message

Messages were developed around the commercial value of the partnership for the pharmacy.

02

Paid acquisition

The distribution focused on audiences and placements showing the strongest indication of intent.


03 · The Application

Creative, media, and data moved together.

The team monitored the quality of the traffic flow, not just the cheapest click. Decisions aimed at improving the final CPL and the sales utility of the leads.


04 · THE RESULTS

122 specific opportunities for partner development.

122

Pharmacy leads

With an estimated cost per lead of approximately €11 within the recorded reporting period.


05 · THE MEASUREMENT

What each number means.

Interaction

Recorded interaction with the advertising content.

Link click

Click that led the user to the conversion experience.

Lead

Submission of expression of interest by a prospective pharmacy partner.

Source: Approved data from the internal Qualityweb report for the 2025 reporting period. The metrics are presented within their business context and do not constitute a guarantee of future performance.